scispace - formally typeset
G

Gideon Koren

Researcher at Ariel University

Publications -  2007
Citations -  88165

Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.

Papers
More filters
Journal ArticleDOI

Optical and electrical enhancement of flux creep in YBa 2 Cu 3 O 7 − δ epitaxial films

Eli Zeldov, +5 more
- 26 Jun 1989 - 
Journal ArticleDOI

Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis.

Lori E. Ross, +10 more
- 01 Apr 2013 - 
TL;DR: Although statistically significant associations between antidepressant exposure and pregnancy and delivery outcomes were identified, group differences were small and scores in the exposed group were typically within the normal ranges, indicating the importance of considering clinical significance.
Journal ArticleDOI

The relationship between stress and hair cortisol in healthy pregnant women.

Sanjog Kalra, +4 more
- 01 Apr 2007 - 
TL;DR: The findings corroborate recent primate studies with induced stress, and suggest that hair cortisol is a potential biomarker of chronic stress in pregnancy.
Journal ArticleDOI

Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study

Ragnhild Eek Brandlistuen, +4 more
- 01 Dec 2013 - 
TL;DR: Children exposed to long-term use of paracetamol during pregnancy had substantially adverse developmental outcomes at 3 years of age, and Ibuprofen exposure was not associated with neurodevelopmental outcomes.
Journal ArticleDOI

Pregnancy Outcome Following Gestational Exposure to Venlafaxine: A Multicenter Prospective Controlled Study

Adrienne Einarson, +11 more
- 01 Oct 2001 - 
TL;DR: The results suggest that the use of venlafaxine during pregnancy does not increase the rates of major malformations above the baseline rate of 1%-3%.